Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Middle or Upper Third Gastric Cancer (LSPLN)
Study on Long-term Outcome of Laparoscopic Spleen-Preserving D2 Lymphadenectomy With and Without No. 10 Lymph Node Dissection for Advanced Gastric Cancer
Sponsor: Fujian Medical University
This NA trial investigates Stomach Neoplasms and is currently ongoing. Fujian Medical University leads this study, which shows 10 recorded versions since 2015 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
▶ Show 5 earlier versions
-
Aug 2020 — Oct 2020 [monthly]
Active Not Recruiting NA
-
Jun 2020 — Aug 2020 [monthly]
Active Not Recruiting NA
-
Mar 2020 — Jun 2020 [monthly]
Active Not Recruiting NA
Phase: PHASE3 → NA
-
Jun 2018 — Mar 2020 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fujian Medical University
For direct contact, visit the study record on ClinicalTrials.gov .